Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

Jennerex completes enrollment in Phase 2b trial of liver cancer drug By PBR Staff Writer
Jennerex Biotherapeutics has completed enrolling 120 patients in Phase 2b trial of Pexa-Vec (JX-594, pexastimogene devacirepvec) for the treatment of liver cancer.
Contract Research & Services > Clinical Trials > News
Sanofi, Regeneron announce positive Phase 2a study results of asthma drug By PBR Staff Writer
Sanofi and Regeneron Pharmaceuticals have announced positive Phase 2a study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe allergic asthma.
Contract Research & Services > Clinical Trials > News AbbVie begins atrasentan Phase 3 diabetic nephropathy study By PBR Staff Writer
AbbVie has begun Phase 3 study of atrasentan on renal outcomes including the onset of end-stage renal disease (ESRD) transplant or death due to renal failure progression in patients with diabetic nephropathy.
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Pfizer discontinues Phase 3 non-hodgkin lymphoma study of inotuzumab ozogamicin
21 May 2013 | By PBR Staff Writer
Pfizer has discontinued Phase 3 randomized study of inotuzumab ozogamicin in relapsed or refractory aggressive non-hodgkin lymphoma (NHL) due to futility.
Contract Research & Services > Clinical Trials > News
Cellular enrolls 50% patients in Phase I knee osteoarthritis trial
20 May 2013 | By PBR Staff Writer
Cellular Biomedicine has achieved 50% enrollment milestone in Phase I open label clinical research trial for knee osteoarthritis (KOA).
Contract Research & Services > Clinical Trials > News
Novo Nordisk reports positive results from Phase-3 haemophilia B study of N9-GP
20 May 2013 | By PBR Staff Writer
Novo Nordisk has reported positive results from Phase-3 study of FIX derivative N9-GP to treat haemophilia B.
Contract Research & Services > Clinical Trials > News
NW Bio Phase III trial with DCVax-L for brain cancer commences at King's College Hospital
17 May 2013 | By PBR Staff Writer
Northwest Biotherapeutics (NW Bio) has announced that the King's College Hospital in the UK commenced Phase III trial with DCVax-L for brain cancer.
Contract Research & Services > Clinical Trials > News
Trillium Therapeutics completes dosing in Phase I study of TTI-1612
17 May 2013 | By PBR Staff Writer
Trillium Therapeutics, a wholly owned subsidiary of Stem Cell Therapeutics, has completed dosing of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) in first phase study of TTI-1612.
Contract Research & Services > Clinical Trials > News
Boehringer's afatinib, nintedanib found to improve progression-free survival in advanced NSCLC patients
17 May 2013 | By PBR Staff Writer
Boehringer Ingelheim has unveiled data from two different Phase III clinical trials, involving oncology compounds afatinib and nintedanib in patients with advanced non-small cell lung cancer (NSCLC).
Contract Research & Services > Clinical Trials > News
Soligenix begins Phase 1 Crohn's disease study with SGX203
16 May 2013 | By PBR Staff Writer
Soligenix has begun Phase 1 study with SGX203 for the treatment of paediatric Crohn's disease.
Contract Research & Services > Clinical Trials > News
Bayer commences phase III trial of Stivarga tablets to treat hepatocellular carcinoma
16 May 2013 | By PBR Staff Writer
Bayer HealthCare has announced that the patient enrollment has commenced for Resorce (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), a phase III trial to assess the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma (HCC), who have progressed on Nexavar (sorafenib) tablets.
Contract Research & Services > Clinical Trials > News
OncoMed commences OMP-59R5 Phase 1b/2 small cell lung cancer trial
15 May 2013 | By PBR Staff Writer
OncoMed Pharmaceuticals has commenced Phase 1b/2 trial of anti-cancer stem cell therapeutic OMP-59R5 (Anti-Notch2/3) in small cell lung cancer (SCLC) patients.
Contract Research & Services > Clinical Trials > News
COPA-DATA establishes new branch office in Ludwigshafen am Rhein
14 May 2013
COPA-DATA Germany GmbH continues to promote long-term and sustainable growth and establishes a new branch office in Ludwigshafen am Rhein. The goal is to provide even better support and service to existing local customers as well as gain new customers in the Rheinland-Pfalz area. Furthermore, COPA-DATA has founded the "Competence Center Business Intelligence" at the new location, in order to meet the increasing demand for information analysis and evaluation solutions.
Contract Research & Services > Clinical Trials > Press Releases
View all Clinical Trials news or find news targeted to your interests

Buy the latest industry research online today!
African Pharmaceutical Directory 2013 01 February 2013 API research into pharmaceutical companies and corporations Buy online from $200